Karen Bisnauthsing

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Jeffrey Seow, Carl Graham, Blair Merrick et al. · Nature Microbiology · 2020 · 1.4K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 1K citations · Full text

Oral versus Intravenous Antibiotics for Bone and Joint Infection

Ho Kwong Li, Ines Rombach, Rhea Zambellas et al. · New England Journal of Medicine · 2019 · 850 citations · Full text